Schedule 13D ownership disclosure
Biohaven Pharmactl Hldg Co
Security class unavailable · CUSIP: G11196105
Event date: 2017-05-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-028624
- Form type
- SC 13D
- Filer
- Biohaven Pharmaceutical Holding Co Ltd.
- CIK
- CIK 1689813
- Filed
- May 19, 2017
- Reporting period
- May 09, 2017
- Description
- Schedule 13D beneficial ownership